GT Biopharma, Inc.
GTBP· Nasdaq
GTBPGT Biopharma, Inc.
Filed Nov 21, 2012 · 10-Q · 52 days after period end · 0001513160-12-000090
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $120.00K | $2.00K | $0.00 |
| Net Income | -$1.40M | $23.00K | -$633.00K |
| EPS Diluted | $0.00 | $0.00 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GT Biopharma, Inc. · CIK 109657 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 21, 2012 · 52 d after period end
